Retinoblastoma: eye cancer in infants and young children
September10th,2010Retinoblastoma corresponds to a cancerous tumor of the eye, which affects the cells of the retina. His diagnosis is relatively straightforward, is still too late. To remedy this, the Institut Curie has developed genetic counseling.
Serious but rare (1 in 15,000 to 20,000 births), retinoblastoma affects the cells of the retina in infants and young children. Often hereditary, this disease can affect one eye (60% of cases) or both.
A white reflection in the pupil (leukocoria) or the resistance of strabismus are signs to be taken very seriously and requires an eye examination as soon as possible. Indeed, early diagnosis is a key element that determines the possibilities of conservative treatment and visual prognosis of the child. Too late, it may even affect the prognosis.
Major therapeutic advances have been made in recent years. The treatments of today, more and more effective, can cure up to 95% of children in developed countries. It is now vital to improve early screening.
With the identification of the retinoblastoma susceptibility gene and the subsequent development of genetic tests estimating the risk of each tumor, the Institut Curie has developed genetic counseling, “they are for families with retinoblastoma. Research a genetic predisposition, now offered to all children who have retinoblastoma, can either raise ophthalmologic monitoring in relatives that are not carriers of the predisposition is to further improve the monitoring of related carriers. ”
Researchers from the Institute Curie also state that this test may be offered to adults who have had retinoblastoma in childhood, to determine whether there is a risk to their offspring.